RESEARCH-USE BIOSIMILAR ANTIBODY

Adintrevimab

Monoclonal antibody · IgG1

SARS-CoV-2 SpikeIgG1RUO

Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV (SARS-CoV) antibody. Adintrevimab inhibits SARS-CoV-2 variants and other SARS-like coronaviruses with pandemic potential.

TARGETSARS-CoV-2 Spike
YMonoclonal antibody
CATALOGSC-BS-779
CATALOG NUMBERSC-BS-779
MOLECULAR WEIGHTApprox. 145.04 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV (SARS-CoV) antibody. Adintrevimab inhibits SARS-CoV-2 variants and other SARS-like coronaviruses with pandemic potential.

Adintrevimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte